SigTuple has raised Rs 34.5 crores ($4.3 million) in a fresh round of funding - led by existing investors Endiya Partners and Accel, with participation from a few strategic leaders from the Healthcare sector

SigTuple has raised Rs 34.5 crores ($4.3 million) in a fresh round of funding - led by existing investors Endiya Partners and Accel, with participation from a few strategic leaders from the Healthcare sector. The team will use this new capital to drive geographical expansion, expand its product portfolio and support regulatory clearances, the company said in a statement on Wednesday.

Since 2020, the company has been laser-focused on its core product (AI100), which is now getting traction in the Indian market, over the last few months, SigTuple has onboarded 2 of the largest medical device distributors as channel partners for sales and service in India – Horiba Medical and Genworks Health.

Commenting on this, Tathagato Rai Dastidar Founder & CEO - SigTuple said, “The last 1 year has been truly transformative for the organization - with major product improvements, new product additions and most importantly - strong customer traction. While we continue to build on the success of AI100 in India, 2023 is the year SigTuple will go global - with expansions planned across key markets in SEA, MENA, North America & Europe.”  

Dr Ramesh Byrapaneni, Managing Director, Endiya Partners, said “We at Endiya Partners are thrilled to be part of SigTuple's groundbreaking journey in providing AI solutions to Pathology and Microbiology. SigTuple is solving an important problem by combining state-of-the-art digitization and AI technology for peripheral blood smears and urine samples, the two most common tests in Pathology Labs worldwide.” 

The diagnostic sector in India holds immense potential for growth and development. SigTuple's digital solutions are at the forefront of innovation, and their dedication to enhancing patient outcomes is truly remarkable. We at Accel are excited to witness the positive impact that SigTuple's technology will undoubtedly have on countless lives, said Barath Shankar Subramanian, Partner at Accel.